# The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients

> **NCT00791076** · PHASE2 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 8 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Placebo
- **DRUG:** Pancreatic Polypeptide (PP)

## Key facts

- **NCT ID:** NCT00791076
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** PI left JHU
- **Last updated:** 2017-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791076, "The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00791076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*